Andrew Haller

Andrew Haller is an accomplished professional with extensive experience in the fields of biotechnology, pharmacology, and business development. Currently serving as an Editor at Mednet and a Partner in Business Development at Launchit Solutions, Andrew plays a strategic role in several startups within the LaunchIt Ventures portfolio. In addition, Andrew holds advisory and board positions with ventureLAB and BioCache™ Lab Solutions, respectively, while acting as Principal at Accelerant Biotech Consulting, providing expertise in business development strategy and market research. As an Adjunct Lecturer at the University of Toronto's Faculty of Medicine, Andrew focuses on drug development, AI applications in medicine, and entrepreneurship in bio-innovation. Previously, Andrew was the Founder and CEO of Phoenox Pharma, and has contributed significantly to clinical trials through roles at Clinical Trials Ontario. Andrew possesses a Ph.D. in Molecular Pharmacology and Cancer Therapeutics from the University at Buffalo, along with graduate and undergraduate qualifications in toxicology and biochemistry.